周海蒙,潘扬,冯昌宗,马思星,殷艳花
ZHOU Hai-meng 1* *; PAN Yang 1* * *; FENG Chang-zong 1; MA Si-xing 1; YIN Yan-hua 2 (1.Department of Surgery;

• 1:贵阳医学院附院普通外科
• 2:贵阳医学院附院普通外科
• 3:贵阳医学院附院普通外科
• 4:贵阳医学院附院普通外科

摘要(Abstract)：

目的:探讨血浆纤溶酶原激活物抑制物1(PAI 1)水平在手术前、后的改变,分析PAI 1水平改变及 其基因4G/5G多态性与手术后深静脉血栓(DVT)形成的关系。方法:发色底物法检测24例正常对照和29例 行中等手术治疗患者术前、术后24h、术后72h血浆PAI 1活性,运用聚合酶链反应(PCR)技术检测各研究个体 的基因型。结果:(1)PAI 1活性与甘油三酯之间有显著相关性(r=0.583;P<0.01);(2)PAI 1活性在手术后 24h,72h较术前有增高的趋势,但差异无统计学意义;(3)各不同基因型患者之间手术前后PAI 1活性变化差异 无显著性。结论:(1)手术后患者机体纤溶功能受到一定程度的抑制;(2)PAI 1及其基因4G/5G多态性在行中 型手术治疗患者中,不能作为手术后DVT形成的高危预测因素。手术后DVT的形成可能与手术的类型、大小、 部位以及手术后长期卧床等其它高危因素有关。
Objective: To measure the change of PAI-1 activity in pre- and post-operation, and to explore the possible relationship between the change of PAI-1 activity and its gene 4G/5G Polymorphism and deep venous thrombosis after operation. Method: PAI-1 activity was examined in 24 healthy people (as control) and 29 patients undergoing moderate operation before and 24 and 72 hours after operation. PAI-1 genotypes of all cases were detected by polymerase chain reaction (PCR). Results: 1) Triglycerides was significantly associated with PAI-1 activity (r=0.583,P=0.001). 2) PAI-1 activity was elevated in 24, 72 hours after operation compared with that before operation, but the difference was not significant. 3) The changes of PAI-1 activity during operation in different genotypes were not significantly different. Conclusions: 1) The fibrinolysis of patients undergoing moderate operation was inhibited after operation to some degree. 2) PAI-1 and its 4G/5G polymorphism can not be a predictor of deep venous thrombosis after moderate operation. The occurrence of deep venous thrombosis after operation might be correlated with the operative type, operation size and place, and other risk factors.

关键词(KeyWords)： 纤溶酶原激活物抑制物1;多态现象;手术后并发症;静脉血栓形成
plasminogen activator inhibitor 1; polymorphism; postoperative complications; venous thrombosis

Abstract:

Keywords:

基金项目(Foundation): 贵州省卫生厅资助项目(G2000 8)

作者(Authors): 周海蒙,潘扬,冯昌宗,马思星,殷艳花
ZHOU Hai-meng 1* *; PAN Yang 1* * *; FENG Chang-zong 1; MA Si-xing 1; YIN Yan-hua 2 (1.Department of Surgery;

DOI: 10.19367/j.cnki.1000-2707.2005.01.003

参考文献(References)：

• [1]康兰,李小鹰,李金生,等.血浆纤溶酶原激活物抑制剂1基因启动子区4G/5G多态性与周围动脉闭塞性疾病关系的研究[J].中华老年心脑血管病杂志,2003,5(2):94-95.
• [2]张晨,李江,李玲.PAI 1启动子区插入/缺失(5G/4G)多态性与脑血管病的相关性研究[J].中华医学遗传学杂志,2001,18(5):386.
• [3]MikkelssonJ,PreolaM,WartiovaataU,etal.Plasminogen activatorinhibitor1(PAI 1)4G/5Gpolymorphism,coro narythrombosis,andmyocardialinfarctioninmiddle agedFinnishmenwhodiedsuddenly[J].ThrombHaemost,2000,84(1):78-82.
• [4]StegnarM,UhrinP,PeternelP,etal.The4G/5Gsequence polymorphisminthepromoterofplasminogenactivatorin hibitor1(PAI 1)gene:relationshiptoplasmaPAI 1level invenousthromboembolism[J].ThrombHaemost,1998,79(5):975-979.
• [5]ChowKM,SzetoCC,SzetoCY,etal.Plasminogenactivator inhibitor1polymorphismisassociatedwithprogressiverenal dysfunctionafteracuterejectioninrenaltransplantrecipi ents[J].Transplantation,2002,74(12):1791-1794.
• [6]LahlouA,PeraldiMN,ThervetE,etal.Chronicgraftdys functioninrenaltransplantpatients:potentialroleofplas minogenactivatorinhibitortype1[J].Transplantation,2002,73(8):1290-1295.
• [7]ErikssonP,KallinB,FerdinandM,etal.Allele specificin creaseinbasaltranscriptionoftheplasminogen activator inhibitor1geneisassociatedwithmyocardialinfarction[J].ProcNatlAcadSci,1995,92(6):1851-1855.
• [8]SeguiR,EstellesA,MiraY,etal.PAI 1promoter4G/5G genotypeasanadditionalriskfactorforvenousthrombosis insubjectswithgeneticthrombophilicdefects[J].BrJ Haematol,2000,111(1):122-128.
• [9]叶平,肖延中,张根菊,等.高甘油三酯血症与血凝纤溶系统的关系[J].中国动脉粥样硬化杂志,1998,6(4):333-335.
• [10]刘秉文.血浆甘油三酯与动脉粥样硬化[J].心血管病学进展,1999,20(1):3-6.
• [11]JuhanVagueI,AillaudMF.Progressinfibrinolysis:the fastactinginhibitoroftissue typeplasminogenactivatoris anacutephasereactant[M].Edinburgh:ChurchillLiv ingstone,1985.146-149.
• [12]GunterC,PeterH,ChristophK,etal.Antifibrinolytic propertiesofthevascularwall[J].ArterioThrombVasicBiol,1997,17:723.
• [13]TeresaP,MartinS,ChangXunLi,etal.Comparativea nalysisofplasminogenactivatorinhibitor1expressionin differenttypesofatheroscleroticlesionsincoronaryarter iesfromhumanheartexplants[J].CardiovascRes,1997,36:28.
• [14]刘宿,周蓉,刘怀琼.肾移植术中受者机体抗凝系统的变化[J].中华器官移植杂志,2001,22(4):213.
• [15]ErikssonBI,HultmanE,MartinellS.etal.Regionalfibri nolysisfollowingtotalhipreplacement[J].ThrombRes,1991,62(5):441-447.
• [16]何锡强,刘怀琼,葛衡江,等.前列腺切除病人围术期凝血纤溶功能的动态变化及临床意义[J].中华麻醉学杂志,1999,19(5):272.
• [17]刘宿,毕敏.创伤病人围手术期凝血纤溶功能的变化[J].临床麻醉学杂志,1998,14:57-58.
• [18]DahlOE,PedersenT,Kiereful,etal.Sequentialintrapul monaryandsystemicactivationofcoagulationandfibri nolysisduringandaftertotalhipreplacementsurgery[J].ThrombRes,1993,70:451-458.
• [19]Westrich,GeoffreyHMD,WekslerBMD,etal.Correla tionofthrombophiliaandhypofibrinolysiswithpulmonary embolismfollowingtotalhiparthroplasty:ananalysisof geneticfactors[J].BoneandJointSurgery,2002,84(12):2161-2167.

文章评论(Comment)：